Pictet Asset Management (Switzerland)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio RETA Stock Details RETA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$270K	Sell
2023 Q1	$291K	Buy
2021 Q4	–	Sell
2021 Q3	$9.92M	Buy